BriaCell Therapeutics Corp. BCTX
3.10 USD +0.06 +1.97%
As of Nov 2, 10:47 AM ET
- YTD
- -56.40%
- 1 year
- -71.82%
- Open
- 3.07
- Prev close
- 3.04
- Mkt cap
- 27.33M
- Vol
- 21.55K
- Avg vol
- 266.69K
- EPS
- -6.97
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.06
- High
- 3.20
- Forward P/E
- -1.38
- Beta
- 1.82
- Short ratio
- 0.77
- Inst. own
- 4.65%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Oct 28, 2024
- 50-d avg
- 0.7918
- 200-d avg
- 1.27
- 1y target
- 15.00
5D chart
Chart tools
Chart is warming up
The five-day price history for BCTX has not been loaded yet. Try again in a moment.
Altman Z-Score
-10.68 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 4
P/E -0.5×
P/S 0.0×
P/B 1.1×
P/FCF -0.6×
EV/EBITDA -0.2×
EV/Sales 0.0×
FCF Yield -167.0%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -212.8%
ROIC -228.3%
ROA -148.0%
Revenue 0.0%
Operating Income 5.6%
EPS (diluted) 88.9%
Free Cash Flow 26.3%
Current Ratio 2.8×
Quick Ratio 2.8×
Debt / Equity 0.0×
Net Debt / EBITDA 0.3×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2026-07-31
